Three pharma companies have formed a not-for-profit organisation, the Asian Cancer Research Group (ACRG), to boost work on treating common …
Japanese regulators have approved three new Novartis medicines for use patients with type II diabetes, high blood pressure and advanced …
AstraZeneca has signed another licensing deal to bolster its anti-infectives business, this time signing a deal with Korean company CrystalGenomics …
Merck KGaA has bought an Indian company specialising in research products in a deal it says will make it one …
The government of India has accepted the findings of a report into its patent laws, which recommends maintaining a higher …
Eight manufacturers of generic medicines in the UK have been forced to withdraw batches of product from the market because …
Spanning one third of the globe's circumference and home to more than half of the world's population, the Asia Pacific …
The European Directorate on the Quality of Medicines has suspended the certificates of suitability (CEPs) of four active pharmaceutical ingredients …
France's Sanofi-Aventis is planning a major capital investment programme in Beijing in a bid to bolster its position in the …
An accord signed by economic ministers of the Association of Southeast Asian Nations, aimed at bringing manufacturing standards into line, …
Eli Lilly has forged a research collaboration with India's Zydus Cadila that sees the two companies combine their efforts in …
Pfizer has linked up with Indian drug manufacturer Aurobindo Pharma to expand its portfolio of generic medicines in the US …
Bayer Schering Pharma's plan to build a 100 million-euro R&D centre in Beijing marks the company's first major foray into …
Novartis is to open a major, new pharmaceutical research and development centre in China, becoming the first company in the …